#AI #Stock News: GBT Tokenize (OTCPINK: $GTCH) to Add Blood Pressure Measurement Feature to qTerm Device - Version II Aim to Release Q1/2021 @GbtTechnologies #artificialintelligence
San Diego, CA, November 5, 2020 - (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT”, or the “Company”), announced that its joint Venture GBT Tokenize Corp (“GBT/Tokenize”) is currently developing an additional feature for its qTerm device. The additional feature will be a blood pressure measurement system and it is planned to be released with the product's second release during Q1 2021.
Read this in full
at https://www.investorideas.com/CO/GOPH/news/2020/11051qTerm-Blood-Pressure-Measurement.asp
Typical
blood-pressure apparatus is built using bulky and mechanical cuff-based medical
devices. qTerm is planned to introduce a solid-state based blood-pressure
monitoring solution, in order to enable a more convenient measurement system
that will make tracking and monitoring easier.
Cardiovascular disease is a leading factor of death and disability, and
elevated blood pressure is a major contributor to these types of health risks.
Early detection of hypertension can alert users to follow with appropriate
therapy and treatment.
GBT/Tokenize’s
blood pressure solution will comprise a complete integrated optical sensor
module, and an embedded microcontroller. A sensing firmware algorithm will
provide the operation and control of the entire system. Such method is called
photoplethysmography (PPG) and its goal is to detect blood volume changes in
the microvascular tissues. qTerm users will be able to measure blood pressure
simply by placing their finger on the device while resting, at any time and
anywhere.
The
Optical Blood Pressure analysis system works by illuminating the finger's skin
with miniature LED light (Emitted by the sensing system, and controlled by the
embedded microcontroller) and by further capturing the light that is scattered
and modulated by the pulsation of the user's skin arterioles. These signals are
fed into algorithms to mathematically calculate the body's blood pressure.
qTerm device will be enhanced by the addition of a high-sensitivity optical
sensor and microchip on its PCB board. The physical dimensions of the device
are expected to grow slightly. GBT is currently evaluating advanced optical
electronic systems. An integrated optical solution consumes low power and
provides high accuracy. The device also received its TM (Trademark) allowance
notice and will present it on the product/package as required by the United
State Patent Office. The qTerm device is targeted to measure body temperature,
blood pressure, blood oxygen level and heart rate – all with a simple touch of
the finger.
In
order to assist with the world's current situation, GBT/Tokenize has decided to
introduce an initial release of qTerm. The early release of the product will
include body temperature, heart rate and blood oxygen level features and is
targeted to be released by the end of this year. These three (3) vitals
measurements are essential to assist with the pandemic crisis since they
provide important health factors for early viral infection detection. The Blood
Pressure feature is planned to be released in qTerm second release, planned for
Q1 2021.
"Our qTerm device was planned to provide major human vitals, one of them
is blood pressure. We decided to rush our first version to the market in order
to assist with the global pandemic. As qTerm general development is continuing
we are now developing its originally planned feature; blood pressure. Using a
digital embedded sensor electronic system, and machine-learning algorithms we
develop an embedded optical based analysis system to measure blood pressure.
This miniature system will be based on photophlethysmography (PPG) method and installed
within our qTerm medical device" stated Danny Rittman, GBT’s CTO.
"qTerm will measure the amount of light that is absorbed or reflected by
blood vessels in human tissues, calculating responsive changes in the blood's
volume. The sensor coverage area includes veins, arteries, and numerous
capillaries. Software algorithm will calculate and conclude the numerical
results. qTerm will include blood oxygen level, heart rate, body temperature
and blood pressure vitals measurements and all with a touch of a finger, a
none-invasive product. Users will be able to potentially monitor their health,
potentially identify early signs of health issues, and take appropriate care.
Blood pressure is a critical vital to address proper treatment and
management. Many medical conditions require this data and qTerm will be
offering an easy, convenient measurement capability that will enable users to
take the time and potentially monitor their health frequently. No bulkier cuffs
and discomfort measurement devices, but a simple none-invasive touch of a
finger will make the process of blood pressure measurement comfortable, easier
and faster. High blood pressure is associated with many chronic disease
conditions, and is a major source of mortality and disabilities around the world.
The device mobile app will support the additional feature by recording and
analyzing the data. We strongly believe that this feature will be a significant
addition to the qTerm device, making it a comprehensive, easy for use, mainly
intuitive, medical device. We plan to expand the device furthermore the future,
adding more features and AI analysis capabilities" continued Dr. Rittman.
About GBT Technologies Inc.
GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is
a development-stage company which considers itself a native IoT creator,
developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled
mobile technology platforms. GBT has a
portfolio of Intellectual Property that, if commercialized, is designed to
include smart microchips, mobile and security applications and protocols and
supporting cloud software. GBT’s system
envisions the creation of a global mesh network. The core of the system will be its advanced
microchip technology that can be installed in any mobile or fixed device
worldwide. GBT envisions this system as a low-cost, secure, private mesh
network between any enabled devices, providing shared processing, advanced
mobile database management/sharing and enhanced mobile features as an
alternative to traditional carrier services.
Forward-Looking
Statements
Certain
statements contained in this press release may constitute "forward-looking
statements". Forward-looking statements provide current expectations
of future events based on certain assumptions and include any statement that
does not directly relate to any historical or current
fact. Actual results may differ materially from those indicated by such
forward-looking statements as a result of various important factors as
disclosed in our filings with the Securities and Exchange Commission located at
their website ( http://www.sec.gov).
In addition to these factors, actual future performance, outcomes, and results
may differ materially because of more general factors including (without
limitation) general industry and market conditions
and growth rates, economic conditions, governmental and public policy changes,
the Company’s ability to raise capital on acceptable terms, if at all, the
Company’s successful development of its products and the integration into its
existing products and the commercial acceptance of
the Company’s products. The forward-looking statements included in this
press release represent the Company's views as of the date of this press
release and these views could change. However, while the Company may elect to update these forward-looking statements at some
point in the future, the Company specifically disclaims any obligation to do
so. These forward-looking statements should not be relied upon as
representing the Company's views as of any date subsequent to the date of the press release.
Contact:
Dr.
Danny Rittman, CTO
GBT
Technologies Inc.
Media:
press@gopherprotocol.com
GBT Technologies
Inc. (OTCQB:GTCH) is a featured tech stock on
More info on GTCH at Investorideas.com
Visit: https://www.investorideas.com/CO/GOPH/
Get News Alerts on
GBT Technologies Inc GTCH
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Disclosure: GTCH is a PR, social media and publishing client and
compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp
Contact management and IR of each company directly
regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more tech stocks investor ideas- news, articles, podcasts and stock directories
BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences
Like
Biotech Stocks? View our Biotech Stocks Directory
Get News Alerts on
Biotech Stocks
No comments:
Post a Comment